Werewolf Therapeutics, Inc. current report, 01 June 2021

Werewolf Therapeutics, Inc. — Form 8-K Summary

Reporting date: June 1, 2021; filed June 2, 2021. The filing reports entry into a material lease agreement and creation of a direct financial obligation. It does not provide a quarterly or annual financial update.

Business Context and Reporting Period

  • Werewolf Therapeutics entered into a lease with ARE-MA Region No. 75, LLC for approximately 25,778 square feet of office and laboratory space at 200 Talcott Avenue, Watertown, Massachusetts.
  • The company expects to relocate its corporate headquarters to the premises in May 2022.
  • The lease term begins on the Commencement Date, defined by specified completion, permitting, delay, or occupancy conditions, and ends 96 months after the first day of the first full month following that date.

Financial Obligations and Key Terms

  • Base rent begins one month after the Commencement Date at $165,408.83 per month and increases by approximately 3% annually.
  • The company provided a letter of credit of approximately $1.0 million as a security deposit. This amount may be reduced to approximately $0.7 million on the third anniversary of the Commencement Date.
  • The company has an option to extend the lease for an additional five years.
  • The lease created a direct financial obligation under Item 2.03 of Form 8-K.
  • The filing does not provide revenue, profit, cash flow, operating margin, debt-balance, or liquidity metrics.

Material Changes, Outlook, Risks, and Contingencies

  • This filing reflects a new long-term facility commitment and planned headquarters relocation; no comparable-period financial information is presented.
  • Lease obligations include rent, annual rent escalations, the letter-of-credit security deposit, and potential additional rent and other costs under the lease.
  • Events of default include failure to pay amounts due, failure to maintain insurance, abandonment, improper transfer, and certain insolvency events.
  • Upon default, the landlord may generally terminate the lease and seek liquidated damages, including the present value of remaining base and additional rent, subject to specified offsets and limitations.
  • The company may terminate the lease if the premises are not ready for occupancy within a specified period after the anticipated Commencement Date.

Key Facts for Investors to Verify

  • Confirm the actual Commencement Date and whether the anticipated May 2022 relocation occurred.
  • Review the complete lease for additional rent, operating expenses, tenant-improvement terms, termination rights, and default provisions.
  • Assess the effect of the lease and letter-of-credit requirement on future liquidity and operating expenses.
  • Verify future filings for recognition and measurement of the lease obligation and right-of-use asset under applicable accounting standards.